Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Machine learning-assisted diagnosis classification of primary immune dysregulation using IDDA2.1 phenotype profiling
Authors:ID Schwitzkowski, Malte (Author)
ID Veeranki, Sai Pavan Kumar (Author)
ID Seidel, Benedikt N. (Author)
ID Kindle, Gerhard (Author)
ID Rusch, Stephan (Author)
ID Kramer, Diether (Author)
ID Seidel, Markus G. (Author)
ID Avčin, Tadej (Research coworker)
ID Blazina, Štefan (Research coworker)
ID Meško Meglič, Karmen (Research coworker)
ID Kopač, Peter (Research coworker)
ID Markelj, Gašper (Research coworker), et al.
Files:.pdf PDF - Presentation file, download (2,83 MB)
MD5: AA4EFF3B00894DD354F46B92F5EC2D14
 
URL URL - Source URL, visit https://www.jacionline.org/article/S0091-6749(25)01112-1/fulltext
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background Immune dysregulation, including autoimmunity, autoinflammation, allergy, and malignancy predisposition, adds significant disease burden in primary immune disorders (PID) and inborn errors of immunity (IEIs). Objective We evaluated whether the 5-graded immune deficiency and dysregulation activity (IDDA2.1) score, encompassing 21 organ involvement and disease burden parameters, supports diagnosis across a wide spectrum of IEIs. Methods From April 2022 to November 2024, collaborators from 84 centers collected 1,043 IDDA score datasets from 825 patients across 89 IEIs (17 disorders with ≥10 patients each; range, 1-196 per IEI), including 177 scores from 141 treated patients. Supervised machine learning models ( k -nearest neighbors, support vector machine, logistic regression, random forest) classified patients into disease groups and ranked corresponding predictive features, while unsupervised uniform manifold approximation and projection (UMAP) visualized disease-specific clustering. Results Feature analysis reflected clinicians’ recognition of IEI patterns and confirmed internal IDDA score consistency. Phenotype profiles in treated patients remained informative, inversely reflecting anticipated treatment-dependent phenotype amelioration. UMAP effectively distinguished IEIs by IDDA2.1 profiles. Genetic disorder prediction achieved 73% overall accuracy, 70% for the correct monogenic IEI, and 93% within the top 3 predictions; classification reached 43% for IEI–International Union of Immunological Society categories and 59% for 12 “cardinal” IEIs (25 genes). Conclusions Random forest feature importance analysis can inform targeted clinical screening for key disease manifestations. The top 3 prediction approach demonstrates diagnostic potential, but improved accuracy will require larger, globally shared datasets. Small sample sizes for rare diseases highlight the necessity of broader collaboration to enhance AI-assisted clinical decision-making in the future.
Keywords:inborn error of immunity, IEI, primary immune regulatory disorder, PIRD, phenotype-driven disease classification, interoperable patient data, immune deficiency and dysregulation activity (IDDA) score, artificial intelligence, AI, unsupervised and supervised machine learning, ML, primary immune disorder, PID
Publication status:Published
Publication version:Version of Record
Year of publishing:2026
Number of pages:str. 470-485
Numbering:Vol. 157, issue 2
PID:20.500.12556/DiRROS-28803 New window
UDC:616-097:004.8
ISSN on article:1097-6825
DOI:10.1016/j.jaci.2025.10.022 New window
COBISS.SI-ID:262513411 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 7. 4. 2026;
Publication date in DiRROS:08.04.2026
Views:139
Downloads:101
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:The journal of allergy and clinical immunology
Shortened title:J. allergy clin. immunol.
Publisher:Elsevier
ISSN:1097-6825
COBISS.SI-ID:3614228 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:prirojena napaka imunosti, primarna motnja imunske regulacije, fenotipsko vodena klasifikacija bolezni, interoperabilni podatki o pacientih, ocena aktivnosti imunske pomanjkljivosti in disregulacije, umetna inteligenca, nenadzorovano in nadzorovano strojno učenje, primarna imunska pomanjkljivost


Back